2929 N Commerce Parkway
Miramar, FL 33025
July 15, 2021
VIA EDGAR
U.S. Securities and Exchange Commission
Division of Corporation Finance
100 F Street, N.E.
Washington, D.C. 20549
| Attn: | Abby Adams |
| Laura Crotty |
| Re: | HCW Biologics Inc. |
| Registration Statement on Form S-1 |
| File No. 333-256510 |
Ladies and Gentlemen:
HCW Biologics Inc. hereby withdraws its request that the Securities and Exchange Commission declare the above-referenced Registration Statement effective as of 4:00 p.m., Eastern Time, on July 15, 2021 that was contained in its letter filed as correspondence via EDGAR on July 13, 2021.
| Sincerely, | ||||
| HCW BIOLOGICS INC. | ||||
| By: | /s/ Rebecca Byam | |||
| Name: | Rebecca Byam | |||
| Title: | Chief Financial Officer | |||
| cc: | William L. Hughes, Esq, Orrick, Herrington & Sutcliffe LLP |
| Scott M. Iyama, Esq., Orrick, Herrington & Sutcliffe LLP |
| Hing C. Wong, HCW Biologics Inc. |
| Rebecca Byam, HCW Biologics Inc. |